79 related articles for article (PubMed ID: 29847331)
1. Associations between serum albumin and serious non-AIDS events among people living with HIV.
Ronit A; Hatleberg CI; Ryom L; Bonnet F; El-Sadr W; Reiss P; Weber R; Pradier C; De Wit S; Law M; d'Arminio Monforte A; Lundgren J; Mocroft A; Phillips AN; Sabin CA;
AIDS; 2018 Aug; 32(13):1837-1848. PubMed ID: 29847331
[TBL] [Abstract][Full Text] [Related]
2. Serious clinical events in HIV-positive persons with chronic kidney disease.
Ryom L; Lundgren JD; Law M; Kirk O; El-Sadr W; Bonnet F; Weber R; Fontas E; Monforte AD; Phillips A; Reiss P; de Wit S; Hatleberg CI; Sabin C; Mocroft A;
AIDS; 2019 Nov; 33(14):2173-2188. PubMed ID: 31385862
[TBL] [Abstract][Full Text] [Related]
3. Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014.
Lesko CR; Moore RD; Tong W; Lau B
AIDS; 2016 Jun; 30(9):1447-55. PubMed ID: 26990627
[TBL] [Abstract][Full Text] [Related]
4. CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy.
Madeddu G; Monforte AD; Girardi E; Di Biagio A; Lo Caputo S; Piolini R; Marchetti G; Pellizzer G; Giacometti A; Galli L; Antinori A; Lepri AC;
J Int AIDS Soc; 2014; 17(4 Suppl 3):19509. PubMed ID: 25394018
[TBL] [Abstract][Full Text] [Related]
5. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
Ryom L; Lundgren JD; De Wit S; Kovari H; Reiss P; Law M; El-Sadr W; Monforte AD; Mocroft A; Smith C; Fontas E; Dabis F; Phillips A; Sabin C;
AIDS; 2016 Jul; 30(11):1731-43. PubMed ID: 26752282
[TBL] [Abstract][Full Text] [Related]
6. Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People.
Sunil M; Nigalye M; Somasunderam A; Martinez ML; Yu X; Arduino RC; Utay NS; Bell TK
AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1205-1209. PubMed ID: 27344921
[TBL] [Abstract][Full Text] [Related]
7. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
[TBL] [Abstract][Full Text] [Related]
8. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.
Althoff KN; Gebo KA; Moore RD; Boyd CM; Justice AC; Wong C; Lucas GM; Klein MB; Kitahata MM; Crane H; Silverberg MJ; Gill MJ; Mathews WC; Dubrow R; Horberg MA; Rabkin CS; Klein DB; Lo Re V; Sterling TR; Desir FA; Lichtenstein K; Willig J; Rachlis AR; Kirk GD; Anastos K; Palella FJ; Thorne JE; Eron J; Jacobson LP; Napravnik S; Achenbach C; Mayor AM; Patel P; Buchacz K; Jing Y; Gange SJ;
Lancet HIV; 2019 Feb; 6(2):e93-e104. PubMed ID: 30683625
[TBL] [Abstract][Full Text] [Related]
9. High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study.
Liu J; Hou Y; Sun L; Wang L; He Y; Zhou Y; Xu L; Liu X; Zhao F; Zhang L; Wang H; Wang FS
Emerg Microbes Infect; 2021 Dec; 10(1):416-423. PubMed ID: 33620297
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
[TBL] [Abstract][Full Text] [Related]
11. Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
Ronit A; Sharma S; Baker JV; Mngqibisa R; Delory T; Caldeira L; Ndembi N; Lundgren JD; Phillips AN;
J Infect Dis; 2018 Jan; 217(3):405-412. PubMed ID: 29244111
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease.
Borges ÁH; Lundgren JD; Ridolfo A; Katlama C; Antunes F; Grzeszczuk A; Blaxhult A; Mitsura VM; Doroana M; Battegay M; Gargalianos P; Mocroft A;
AIDS; 2014 Nov; 28(17):2565-71. PubMed ID: 25574959
[TBL] [Abstract][Full Text] [Related]
13. Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
De Socio GV; Pucci G; Baldelli F; Schillaci G
BMC Infect Dis; 2017 Jun; 17(1):414. PubMed ID: 28606059
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
Ryom L; Lundgren JD; El-Sadr W; Reiss P; Kirk O; Law M; Phillips A; Weber R; Fontas E; d' Arminio Monforte A; De Wit S; Dabis F; Hatleberg CI; Sabin C; Mocroft A;
Lancet HIV; 2018 Jun; 5(6):e291-e300. PubMed ID: 29731407
[TBL] [Abstract][Full Text] [Related]
15. Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.
Zhang S; van Sighem A; Kesselring A; Gras L; Prins JM; Hassink E; Kauffmann R; Richter C; de Wolf F; Reiss P;
HIV Med; 2015 May; 16(5):265-72. PubMed ID: 25604160
[TBL] [Abstract][Full Text] [Related]
16. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
17. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
18. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
[TBL] [Abstract][Full Text] [Related]
19. Infection-related and -unrelated malignancies, HIV and the aging population.
Shepherd L; Borges Á; Ledergerber B; Domingo P; Castagna A; Rockstroh J; Knysz B; Tomazic J; Karpov I; Kirk O; Lundgren J; Mocroft A;
HIV Med; 2016 Sep; 17(8):590-600. PubMed ID: 26890156
[TBL] [Abstract][Full Text] [Related]
20. CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV.
Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J
Clin Infect Dis; 2013 Jul; 57(2):314-21. PubMed ID: 23575194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
